Related Experiment Video
Updated: Sep 24, 2025
06:27
Accelerated Type 1 Diabetes Induction in Mice by Adoptive Transfer of Diabetogenic CD4+ T Cells
Published on: May 6, 2013
16.9K
Host gene effects on gut microbiota in type 1 diabetes
Keyu Guo1, Juan Huang1,2, Zhiguang Zhou1
1National Clinical Research Center for Metabolic Diseases, Key Laboratory of Diabetes Immunology (Central South University), Ministry of Education, and Department of Metabolism and Endocrinology, The Second Xiangya Hospital of Central South University, Changsha, China.
Biochemical Society Transactions
|May 6, 2022
Summary
Host genes influence gut microbiome composition, impacting islet autoimmunity in type 1 diabetes (T1D). Understanding these interactions is key for developing new diagnostic and treatment strategies for T1D.
Area of Science:
- Immunology
- Microbiology
- Genetics
Background:
- Type 1 diabetes (T1D) is an autoimmune disease causing pancreatic beta-cell loss.
- Genetic and environmental factors contribute to T1D, with many risk variants in immunity genes.
- The gut microbiome's role in T1D is increasingly recognized, but host gene-microbiota links remain unclear.
Purpose of the Study:
- To review the impact of host genes on gut microbiota diversity and function in T1D development.
- To explore the relationship between T1D susceptibility genes and gut microbiota composition.
- To highlight the significance of host gene-gut microbiota interactions in T1D.
Main Methods:
- Literature review of studies on host genetics, gut microbiota, and T1D.
- Analysis of evidence from T1D models, such as the non-obese diabetic (NOD) mouse.
- Synthesis of findings on how genetic loci influence microbiome composition and islet autoimmunity.
Main Results:
- Host genes significantly shape gut microbiome composition in the context of T1D.
- Genetic loci can modulate islet autoimmunity by altering gut microbiota.
- Interactions between host genetics and the gut microbiome are crucial in T1D pathogenesis.
Conclusions:
- Understanding host gene-gut microbiota interactions is vital for T1D research.
- These interactions offer potential for novel diagnostic and prognostic biomarkers for T1D.
- Targeting host-microbiome pathways may lead to effective T1D treatment strategies.
Related Concept Videos
01:22Diabetes Mellitus: Overview and Type I Subtype
3.3K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
3.3K
01:22Diabetes Mellitus: Type 2 and Gestational
3.0K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
3.0K
01:20Pathophysiology of Diabetes
1.3K
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
1.3K
01:27Glucose Transporters
24.7K
Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
24.7K
01:50What is Monogastric Digestion?
72.7K
The human body contains a monogastric digestive system. In a monogastric digestive system, the stomach only contains one chamber in which it digests food. Several other animal species also have monogastric digestive systems, including pigs, horses, dogs, and birds. This chapter, however, focuses on the human digestive system.
72.7K
01:19Oral Hypoglycemic Agents: α-Glucosidase Inhibitors
289
α-glucosidase inhibitors, including acarbose (Precose), miglitol (Glyset), and voglibose (Voglib) (primarily available in Asia), are drugs that control blood sugar levels by delaying the digestion of starch and disaccharides. They achieve this by inhibiting α-glucosidase enzymes in the intestine, which slow the absorption of carbohydrates in the intestine, which in turn leads to a prolonged release of the glucoregulatory hormone GLP-1 from intestinal L-cells.
Acarbose and miglitol are...
Acarbose and miglitol are...
289